Non-PVC IV Bags

Non-PVC IV Bags Market Outlook

The global Non-PVC IV Bags market is estimated to reach approximately USD 3.5 billion by 2035, expanding at a robust CAGR of around 9% during the forecast period from 2025 to 2035. The growth of this market can be largely attributed to the increasing demand for safer and environmentally friendly packaging solutions in the healthcare sector, along with the rising awareness regarding the hazardous effects of PVC (Polyvinyl Chloride) in IV bags. Factors such as stringent regulations against the use of PVC in medical products, coupled with the growing emphasis on patient safety and comfort, have resulted in a significant demand for non-PVC alternatives. Furthermore, the shift towards home healthcare and the increasing prevalence of chronic diseases are augmenting the need for more versatile and safer IV solutions, thus propelling the growth of the Non-PVC IV Bags market.

Growth Factor of the Market

The Non-PVC IV Bags market is witnessing remarkable growth driven by a combination of factors that are fostering an environment conducive to innovation and expansion. Firstly, an increased focus on patient safety has led healthcare providers to seek alternatives to traditional PVC IV bags, which are associated with various health risks. Secondly, technological advancements in the materials used for IV bags have resulted in the development of high-performance non-PVC options, enhancing the overall utility and appeal of these products. Additionally, the ongoing shift towards outpatient care and home-based healthcare services has escalated the demand for lightweight, portable, and safer IV solutions. As the healthcare landscape continues to evolve, the rising prevalence of chronic diseases necessitates more effective and reliable methods of drug delivery, further driving the adoption of non-PVC IV bags. Furthermore, regulatory pressure from health authorities globally has prompted manufacturers to diversify their product offerings, thereby creating new opportunities in the market.

Key Highlights of the Market

• The Non-PVC IV Bags market is projected to grow at a CAGR of 9% from 2025 to 2035.
• Increased regulatory scrutiny over PVC materials in healthcare is influencing market dynamics.
• Technological innovations are leading to the development of advanced non-PVC materials.
• Growing demand for homecare solutions is driving the adoption of non-PVC IV bags.
• Asia-Pacific is expected to experience the highest growth rate in the Non-PVC IV Bags market.

By Product Type

Single Chamber:

Single chamber non-PVC IV bags have emerged as a prominent choice in the medical field, primarily due to their simplicity and effectiveness in drug administration. These bags are designed to hold a single solution, making them ideal for straightforward intravenous therapies. Their compatibility with most injectable medications simplifies the preparation process, allowing healthcare professionals to administer treatments more efficiently. Additionally, the lightweight nature of single chamber bags enhances their ease of use, particularly in emergency and outpatient settings. The rise in outpatient procedures and the demand for portable medical solutions further bolster the market for single chamber non-PVC IV bags. Their cost-effectiveness is another key advantage, as hospitals and clinics can procure these bags without incurring excessive expenditure, thus contributing to their growing popularity.

Multi Chamber:

Multi-chamber non-PVC IV bags represent a significant advancement in intravenous drug delivery, primarily designed to hold multiple solutions or medications in separate chambers that can be mixed before administration. This innovative design allows for more complex therapeutic regimens, catering to patients requiring multiple drugs simultaneously. Multi-chamber systems not only enhance patient safety by reducing the risk of contamination but also streamline the preparation process for healthcare providers, which is crucial in high-pressure environments like operating rooms or intensive care units. Furthermore, the convenience of a single container for multiple medications minimizes waste and improves cost efficiency, driving their adoption in hospitals and clinics. As a result, the multi-chamber non-PVC IV bags segment is expected to witness substantial growth in the coming years, reflecting the need for versatility in drug administration methods.

By Material Type

Polyolefin:

Polyolefin-based non-PVC IV bags have gained significant traction due to their superior chemical resistance and compatibility with a wide range of medications, making them a preferred choice in medical applications. Polyolefins, being free from harmful plasticizers commonly found in PVC, ensure a safer delivery of drugs without leaching toxic substances. This characteristic is particularly vital in critical care settings where the purity of the administered solutions is paramount. Additionally, polyolefin materials contribute to the overall strength and durability of IV bags, allowing them to withstand varying pressures during transport and administration. As the healthcare industry continues to prioritize patient safety, the demand for polyolefin non-PVC IV bags is anticipated to grow, supported by ongoing innovations in polymer technology aimed at enhancing performance characteristics.

EVA:

Ethylene Vinyl Acetate (EVA) is another widely used material for non-PVC IV bags, known for its flexibility, transparency, and excellent barrier properties. EVA-based bags are particularly appreciated for their lightweight nature, making them easier to handle and administer in various healthcare settings. The material’s inherent resistance to stress cracking and punctures enhances the safety and reliability of IV solutions, which is critical in emergency situations. Furthermore, EVA provides a good moisture barrier, protecting the contents from degradation and ensuring the stability of sensitive medications. The growing trend of personalized medicine, which often requires precise drug formulations, is also driving the demand for EVA non-PVC IV bags as they can accommodate specialized requirements more effectively. This segment of the market is projected to witness continued growth as healthcare providers seek reliable and safe solutions for intravenous therapy.

Copolyester:

Copolyester non-PVC IV bags are progressively being recognized for their high performance and adaptability in various medical applications. Characterized by exceptional clarity and flexibility, copolyester materials offer an excellent alternative to conventional IV bag materials. Their unique properties allow for the storage of a wide array of drug formulations, including those sensitive to light and temperature. Additionally, copolyester IV bags exhibit enhanced tear and puncture resistance, making them suitable for dynamic environments such as hospitals and clinics that require robust packaging solutions. The growing emphasis on sustainability in the healthcare sector is also contributing to the rising popularity of copolyester, as these materials can be designed to be recyclable and reduce environmental impact. As the demand for innovative and environmentally friendly medical solutions increases, copolyester non-PVC IV bags are positioned to capture a larger share of the market.

Others:

The category of "Others" in the material type segment encompasses alternative polymers and materials used in the production of non-PVC IV bags, which are gaining attention for their unique properties and functionalities. This segment includes materials like polyurethane and various bio-based plastics, which are being explored for their potential in improving the safety and efficacy of intravenous therapies. Manufacturers are increasingly investing in research and development to create materials that not only meet regulatory standards but also enhance patient safety and comfort. The diversification of materials in the non-PVC IV bags market is indicative of the healthcare industry's commitment to innovation and sustainability, as these alternatives often offer improved biocompatibility and reduced environmental impact. As awareness grows regarding the benefits of using these non-traditional materials, the "Others" segment is expected to see substantial growth over the forecast period.

By Application

Hospital:

The hospital segment remains a dominant area of application for non-PVC IV bags, driven by the need for safe and efficient drug delivery systems in various clinical settings. Hospitals often manage a large volume of patients requiring intravenous therapy, necessitating reliable and effective solutions to administer medications. Non-PVC IV bags are preferred in hospitals due to their reduced risk of harmful chemical leaching, enhancing patient safety and treatment outcomes. Additionally, as hospitals increasingly adopt advanced medical technologies and practices, the demand for specialized IV bags that cater to complex therapeutic regimens is on the rise. The ongoing transformation of healthcare towards patient-centered care is also influencing the use of non-PVC IV bags, as they play a crucial role in providing high-quality and safe medical services to patients across diverse medical conditions.

Clinic:

Clinics represent a growing segment for non-PVC IV bag applications, as outpatient care continues to expand. The rise in preventative care and chronic disease management is impelling clinics to adopt more versatile and efficient drug delivery systems, with non-PVC IV bags emerging as a preferred choice. Their lightweight and portable nature makes them ideal for use in smaller clinical settings where rapid and efficient administration of medications is essential. Additionally, the shift towards home healthcare solutions is further influencing this segment, as clinics often provide patients with IV therapy for chronic conditions outside traditional hospital settings. The convenience and safety offered by non-PVC IV bags align with the increasing demand for high-quality and compliant medical products in clinics, driving their adoption in this sector.

Homecare:

The homecare segment has seen significant growth in the utilization of non-PVC IV bags, driven by the increasing preference for at-home medical treatment and monitoring. Patients with chronic illnesses or those requiring long-term intravenous therapy benefit greatly from the availability of non-PVC IV bags, which offer a safer alternative for at-home administration. These bags provide the necessary flexibility and convenience, allowing caregivers and patients to manage treatments effectively in a familiar environment. Furthermore, the growing trend of personalized medicine and tailored therapies is enhancing the appeal of non-PVC IV bags in homecare settings, as they can be customized to meet the specific needs of patients. As the healthcare system continues to shift towards more decentralized models of care, the demand for reliable and user-friendly non-PVC IV bags in homecare is expected to rise significantly.

By End User

Hospitals:

Hospitals are the largest end users of non-PVC IV bags, primarily due to their extensive use in a wide range of medical procedures requiring intravenous drug delivery. As the primary healthcare providers, hospitals demand high-quality, safe, and efficient IV solutions to cater to diverse patient needs. The continued sophistication of medical treatments, particularly in critical care and oncology, necessitates reliable IV systems that prevent contamination and ensure drug stability. Non-PVC IV bags meet these stringent requirements, providing hospitals with optimal solutions that enhance patient safety and treatment outcomes. The increasing focus on patient-centered care in hospitals is propelling the demand for non-PVC IV bags, as healthcare providers seek to improve the quality of care and minimize potential risks associated with traditional PVC materials.

Clinics:

Clinics are increasingly adopting non-PVC IV bags as they expand their services to include intravenous therapies for outpatient care. The growing prevalence of chronic diseases and the rise in demand for preventive healthcare are driving the use of non-PVC IV bags in clinical settings. Clinics often cater to patients requiring regular infusions, such as those undergoing chemotherapy or managing chronic pain, necessitating reliable and safe intravenous solutions. Non-PVC IV bags provide the necessary features, including flexibility, portability, and reduced risk of chemical leaching, aligning with the needs of both healthcare providers and patients. As outpatient services continue to evolve, the role of non-PVC IV bags in clinics is expected to expand, reflecting the ongoing shift towards more patient-focused healthcare delivery models.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are rapidly becoming an important end-user segment for non-PVC IV bags, primarily due to the rise in same-day discharge surgical procedures. ASCs provide outpatient services that require efficient and safe drug administration, making non-PVC IV bags a critical component of their operations. The benefits of these bags, such as enhanced safety and ease of use, are particularly relevant in settings where quick patient turnover is essential. Moreover, the increasing number of minimally invasive surgeries performed in ASCs necessitates reliable IV solutions that can cater to diverse medication regimens. As the healthcare landscape continues to shift towards outpatient care, the demand for non-PVC IV bags in ASCs is expected to grow substantially, reflecting the evolving needs of this segment.

By Region

In the regional analysis of the Non-PVC IV Bags market, North America holds a significant share, accounting for approximately 40% of the global market. The substantial adoption of advanced healthcare technologies, coupled with stringent regulatory frameworks promoting patient safety, drives the demand for non-PVC solutions in the United States and Canada. Additionally, the increased prevalence of chronic diseases and the growing trend of home healthcare are further propelling market growth in this region. The North American Non-PVC IV Bags market is projected to experience a CAGR of around 8% over the forecast period, reflecting the ongoing emphasis on innovative healthcare solutions that prioritize patient safety and environmental sustainability.

Europe is another prominent region in the Non-PVC IV Bags market, contributing significantly to the global landscape. The market share in Europe is estimated to be around 30%, driven by rigorous regulations concerning medical packaging materials and a strong focus on patient safety. The increasing number of hospitals and outpatient facilities in countries such as Germany, France, and the UK is further contributing to the demand for non-PVC IV bags. As the healthcare sector in Europe continues to evolve, characterized by a shift towards more sustainable and safe medical products, the Non-PVC IV Bags market in this region is expected to grow steadily, with a projected CAGR of approximately 7% during the forecast period. Overall, the regional dynamics indicate a robust demand for non-PVC IV bags across major markets globally.

Opportunities

The Non-PVC IV Bags market presents numerous opportunities for stakeholders, particularly in light of the increasing demand for environmentally friendly and patient-safe medical products. With the global healthcare landscape shifting towards sustainability, companies that develop biodegradable or recyclable non-PVC IV bags can capture a substantial share of the market. Innovations in material science, including the exploration of bio-based plastics and advanced polymers, are paving the way for the creation of high-performance IV bags that align with both environmental and safety standards. Furthermore, as healthcare providers increasingly transition to outpatient care models, the demand for portable and user-friendly IV solutions is expected to rise. Companies investing in research and development to introduce novel non-PVC IV bag designs that cater to these changing needs are likely to gain a competitive advantage in the evolving marketplace. The convergence of sustainability trends and healthcare innovations is set to create a fertile ground for growth in the Non-PVC IV Bags market.

Moreover, emerging markets, particularly in Asia-Pacific and Latin America, present significant growth opportunities for non-PVC IV bag manufacturers. The rapid expansion of healthcare infrastructure, coupled with increasing awareness regarding the risks associated with traditional PVC IV bags, is driving the adoption of safer alternatives in these regions. As governments and healthcare organizations prioritize patient safety and quality of care, the demand for non-PVC IV bags is anticipated to surge. Companies looking to expand their footprint in these markets can leverage strategic partnerships with local healthcare providers and distributors to enhance market penetration. Additionally, targeted marketing efforts highlighting the benefits of non-PVC IV bags can help educate healthcare professionals and end-users, further driving demand. The intersection of growth in emerging markets and the ongoing shift towards sustainable medical solutions represents a substantial opportunity for stakeholders in the Non-PVC IV Bags market.

Threats

While the Non-PVC IV Bags market is poised for growth, it faces several threats that could impede its progress. One of the primary challenges is the presence of established competitors who have significant market share and resources to invest in research and development. These larger companies may leverage their economies of scale to offer lower prices for PVC-based products, which could pose a threat to newer entrants seeking to capture market share with non-PVC alternatives. Additionally, fluctuations in raw material prices for non-PVC materials could impact profit margins, particularly for smaller manufacturers who may struggle to absorb increased costs. Regulatory changes in healthcare and packaging standards can also affect market dynamics, as manufacturers must continuously adapt to meet new compliance requirements or risk facing penalties. Lastly, the lack of awareness among healthcare providers and patients about the benefits of non-PVC IV bags compared to traditional options can hinder market growth and slow the transition towards safer alternatives in intravenous therapy.

The threat of alternative drug delivery methods also looms over the Non-PVC IV Bags market. As advancements in drug delivery technologies continue to evolve, healthcare providers may increasingly explore options such as prefilled syringes, inhalers, or transdermal patches, which could reduce reliance on IV bags altogether. Additionally, the ongoing development of telehealth and remote monitoring technologies may shift the focus away from traditional intravenous therapies, thereby impacting the demand for non-PVC IV bags. Companies in this market must remain vigilant and adjust their strategies to address these emerging threats effectively. By innovating continuously and adapting to changing healthcare trends, stakeholders can mitigate potential risks and maintain a competitive edge in the rapidly evolving Non-PVC IV Bags market.

Competitor Outlook

• Baxter International Inc.
• Fresenius Kabi AG
• Medline Industries, Inc.
• IVENIX, Inc.
• Terumo Corporation
• Smiths Medical
• Hollister Incorporated
• Cardinal Health, Inc.
• B. Braun Melsungen AG
• Kchema Medica
• Amcor plc
• West Pharmaceutical Services, Inc.
• Vygon S.A.
• Standard Textile Co., Inc.
• Medtronic plc

The competitive landscape of the Non-PVC IV Bags market is characterized by a diverse range of players, from established multinational corporations to emerging startups focused on innovative medical solutions. Major companies in this market are increasingly focusing on research and development to introduce advanced non-PVC products that meet evolving healthcare standards and patient needs. This competition has led to the introduction of high-performance materials and innovative designs that enhance the safety and efficacy of IV therapy. Furthermore, strategic partnerships, mergers, and acquisitions are prevalent as companies seek to expand their product portfolios and geographical reach. The emphasis on sustainability and patient safety is encouraging manufacturers to rethink their product offerings and align with global trends, thereby intensifying competition within the Non-PVC IV Bags market.

Specific companies, such as Baxter International Inc. and Fresenius Kabi AG, are recognized leaders in the non-PVC IV bag segment, leveraging their extensive experience and resources to drive innovation in this space. Baxter International Inc. is noted for its commitment to improving patient outcomes through the development of safe and effective medical products, continuously investing in technology to enhance the performance of its non-PVC IV bags. Meanwhile, Fresenius Kabi AG has established a strong reputation for delivering high-quality IV solutions, focusing on the production of non-PVC products that meet stringent safety standards. Both companies are well-positioned to capitalize on the growing demand for non-PVC IV bags, reflecting their dedication to advancing healthcare and enhancing patient safety.

Other notable players such as Medline Industries, Inc. and Terumo Corporation are also making significant contributions to this market. Medline Industries, Inc. is recognized for its comprehensive medical supplies and equipment, emphasizing sustainability in its product offerings. The company is actively expanding its range of non-PVC IV bags to cater to the changing preferences of healthcare providers. On the other hand, Terumo Corporation has a strong focus on innovation, investing in advanced manufacturing processes to produce non-PVC IV bags that enhance drug delivery efficiency. As the Non-PVC IV Bags market continues to evolve, these companies, along with several others, are expected to play pivotal roles in shaping market dynamics and driving future growth.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Amcor plc
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Vygon S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 IVENIX, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Kchema Medica
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smiths Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fresenius Kabi AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 B. Braun Melsungen AG
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Cardinal Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hollister Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Medline Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Baxter International Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Standard Textile Co., Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 West Pharmaceutical Services, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Non-PVC IV Bags Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Ambulatory Surgical Centers
  • 6.2 Non-PVC IV Bags Market, By Application
    • 6.2.1 Hospital
    • 6.2.2 Clinic
    • 6.2.3 Homecare
  • 6.3 Non-PVC IV Bags Market, By Product Type
    • 6.3.1 Single Chamber
    • 6.3.2 Multi Chamber
  • 6.4 Non-PVC IV Bags Market, By Material Type
    • 6.4.1 Polyolefin
    • 6.4.2 EVA
    • 6.4.3 Copolyester
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Non-PVC IV Bags Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Non-PVC IV Bags market is categorized based on

By Product Type

• Single Chamber
• Multi Chamber

By Material Type

• Polyolefin
• EVA
• Copolyester
• Others

By Application

• Hospital
• Clinic
• Homecare

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Baxter International Inc.
• Fresenius Kabi AG
• Medline Industries, Inc.
• IVENIX, Inc.
• Terumo Corporation
• Smiths Medical
• Hollister Incorporated
• Cardinal Health, Inc.
• B. Braun Melsungen AG
• Kchema Medica
• Amcor plc
• West Pharmaceutical Services, Inc.
• Vygon S.A.
• Standard Textile Co., Inc.
• Medtronic plc